Foreign stake in Celltrion up in H1 on robust earnings, IR activities
During the same period, foreign investors purchased around 1.8 trillion won in bio companies listed on the benchmark KOSPI, of which 1.6 trillion won was…
- Center1
- Agency1
1 agency rewrite / co-publication detected
Summary
During the same period, foreign investors purchased around 1.8 trillion won ($1.18 billion) in bio companies listed on the benchmark KOSPI, of which 1.6 trillion won was concentrated in Celltrion, the company added. Offshore ownership of the firm rose 3.4 percentage points to 24.5 percent over the past six months as of end-June, according to data provided by the company. Celltrion has said its estimated second-quarter operating profit was 430 billion won, up 77.3 percent on-year, while sales climbed 35.2 percent on-year to 1.3 trillion won.
Furthermore, In September, the company plans to invite around 50 foreign investors to South Korea for a "Research and Development Day" event aimed at promoting the company's R&D competitiveness and explaining long-term goals, it said. Foreign stake in Celltrion up in H1 on robust earnings, IR activities. "We are seeking to continue expanding direct communications with global investors by holding both NDRs and conferences in various areas," Celltrion said.
In addition, Celltrion has been hosting several non-deal road shows in major financial districts, including those in the United States, Tokyo and Singapore, to expand its base among global institutional investors.
Cross-referenced from 2 sources.
Factual coreconfirmed by several independent voices
During the same period, foreign investors purchased around 1.8 trillion won ($1.18 billion) in bio companies listed on the benchmark KOSPI, of which 1.6 trillion won was concentrated in Celltrion, the company added.
reliability low1/2 sourcesOffshore ownership of the firm rose 3.4 percentage points to 24.5 percent over the past six months as of end-June, according to data provided by the company.
reliability low1/2 sourcesCelltrion has said its estimated second-quarter operating profit was 430 billion won, up 77.3 percent on-year, while sales climbed 35.2 percent on-year to 1.3 trillion won.
reliability low1/2 sourcesIn September, the company plans to invite around 50 foreign investors to South Korea for a "Research and Development Day" event aimed at promoting the company's R&D competitiveness and explaining long-term goals, it said.
reliability low1/2 sourcesForeign stake in Celltrion up in H1 on robust earnings, IR activities.
reliability low1/2 sources"We are seeking to continue expanding direct communications with global investors by holding both NDRs and conferences in various areas," Celltrion said.
reliability low1/2 sourcesCelltrion has been hosting several non-deal road shows in major financial districts, including those in the United States, Tokyo and Singapore, to expand its base among global institutional investors.
reliability low1/2 sources
Disputedincompatible versions — to verify
No factual contradiction detected between sources.
Framing by sidesame fact, different words — loaded terms highlighted
No notable framing divergence.
Blind spotwhat one side keeps silent
No blind spot detected: every side covers the same facts.
Sources2 sources cross-checked
Center1
Agency1